Home » Stocks » BioSig Technologies

BioSig Technologies, Inc. (BSGM)

Stock Price: $3.03 USD -1.99 (-39.64%)
Updated Oct 26, 2020 4:00 PM EDT - Market closed
After-hours: $2.95 -0.08 (-2.64%) Oct 26, 7:57 PM

Stock Price Chart

Key Info

Market Cap 90.30M
Revenue (ttm) n/a
Net Income (ttm) -50.77M
Shares Out 29.80M
EPS (ttm) -2.13
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 26, 2020
Last Price $3.03
Previous Close $5.02
Change ($) -1.99
Change (%) -39.64%
Day's Open 2.92
Day's Range 2.81 - 3.60
Day's Volume 3,268,417
52-Week Range 2.36 - 12.43

More Stats

Market Cap 90.30M
Enterprise Value 57.41M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 29.80M
Float 23.08M
EPS (basic) -2.12
EPS (diluted) -2.13
FCF / Share -0.84
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 3.22M
Short Ratio 3.51
Short % of Float 13.96%
Beta 1.44
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 4.48
Revenue n/a
Operating Income -55.89M
Net Income -50.77M
Free Cash Flow -22.22M
Net Cash 32.90M
Net Cash / Share 1.10
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -134.68%
ROE -240.89%
ROIC -2,031.00%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (1)

Buy 1
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

Current: $3.03
Target: 17.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Operating Income-34.60-17.26-12.91-11.16-12.04-7.87-6.24
Net Income-34.08-18.14-12.70-11.59-9.46-8.47-9.80
Shares Outstanding20.6914.5010.227.805.643.863.28
Earnings Per Share-1.65-1.25-1.25-1.50-1.75-2.28-3.08
Operating Cash Flow-15.48-10.26-7.47-5.11-4.52-2.00-1.76
Capital Expenditures-0.17-0.04-0.01-0.02-0.02--0.01
Free Cash Flow-15.66-10.29-7.48-5.12-4.54-2.00-1.77
Cash & Equivalents12.214.501.561.080.980.260.33
Total Debt2.751.20-----
Net Cash / Debt9.463.311.561.080.980.260.33
Book Value11.153.32-3.25-2.79-2.91-3.58-4.96
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name BioSig Technologies, Inc.
Country United States
Employees 33
CEO Kenneth L. Londoner

Stock Information

Ticker Symbol BSGM
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Unique Identifier NASDAQ: BSGM


BioSig Technologies, a medical technology company, engages in developing a proprietary biomedical signal processing platform designed to improve the electrophysiology (EP) marketplace. The company's first product, PURE EPTM System is a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording, and storing of electrocardiographic and intracardiac signals for patients undergoing electrophysiology (EP) procedures in an EP laboratory. The system is indicated for use under the supervision of licensed healthcare practitioners who are responsible for interpreting the data. This novel cardiac signal acquisition and display system is engineered to assist electrophysiologists in clinical decision-making during electrophysiology procedures in patients with abnormal heart rates and rhythms. The company has partnered with Minnetronix on technology development and received FDA 510(k) clearance for the PURE EPTM System in August 2018. It is also developing a library of software tools that are designed to be configured to fit the needs of electrophysiologists in various settings and for arrhythmia treatments. The company has partnership with Albany Molecular Research Inc. for support in undertaking research to investigate the potential of merimepodib to fight SARS-CoV-2, the virus that causes COVID-19 as a standalone treatment or in combination with other anti-viral agents or immune modulators. BioSig Technologies, Inc. was founded in 2009 and is headquartered in Westport, Connecticut.